66 Results for "

mt1

" in MedChemExpress (MCE) Product Catalog:
Products (66)

66 Results for "mt1" in MCE Product Catalog:

  • Isoforms Recommended:
18
18 Publications Verification
Art. -Nr.: HY-101254
CAS. Nr.: 117946-91-5
Reinheit:  100.0%
Synonyms: N-0774
Target:  

Melatonin Receptor

Forschungsgebiete:  

Neurological Disease

Luzindole (N-0774) is a selective melatonin receptor antagonist. Luzindole preferentially targets MT2 (Mel1b) over MT1 (Mel1a) with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively. Luzindole suppresses experimental autoimmune encephalomyelitis (EAE), and exerts antidepressant-like activity [1] .
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-100609
CAS. Nr.: 134865-74-0
Reinheit:  99.90%
Target:  

Melatonin Receptor

Forschungsgebiete:  

Neurological Disease

4-P-PDOT is a potent, selective and affinity Melatonin receptor (MT2) antagonist. 4-P-PDOT is >300-fold more selective for MT2 than MT1. 4-P-PDOT significantly counteracts Melatonin-mediated antioxidant effects (GSH/GSSG ratio, phospho-ERK, Nrf2 nuclear translocation, Nrf2 DNA-binding activity) [1] .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-A0014
CAS. Nr.: 196597-26-9
Synonyms: TAK-375
Target:  

Melatonin Receptor

Forschungsgebiete:  

Neurological Disease Endocrinology Cancer

Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation [1] .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-122136
CAS. Nr.: 296280-56-3
Reinheit:  99.63%
Target:  

Melatonin Receptor

Forschungsgebiete:  

Neurological Disease

S26131 (compound 5) is a potent and selective MT1 melatoninergic ligand, and the Ki values are 0.5 and 112 nM for MT1 and MT2, respectively. S26131 behaves as an MT1 and MT2 antagonist [1].
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-17038
CAS. Nr.: 138112-76-2
Synonyms: S-20098
Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively [1]. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-17038A
CAS. Nr.: 1176316-99-6
Synonyms: S-20098 hydrochloride
Agomelatine hydrochloride (S-20098 hydrochloride) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively [1]. Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-17038B
CAS. Nr.: 824393-18-2
Synonyms: S-20098 L(+)-Tartaric acid
Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively [1]. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-101176
CAS. Nr.: 93515-00-5
Reinheit:  ≥99.0%
Target:  

Melatonin Receptor

Forschungsgebiete:  

Cancer

2-Iodomelatonin is a potent agonist of melatonin receptor 1 (MT1) with a Ki value of 28 pM, it is more 5-fold selective for MT1 over MT2 [1]. 2-iodomelatonin can be used to identify, characterize and localize melatonin binding sites in the brain and peripheral tissues [1].
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-P4931
CAS. Nr.: 720710-69-0
Target:  

MMP

Forschungsgebiete:  

Cancer

Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 (FS-6) is a fluorescent peptide that is a quenched MMP peptide substrate. Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 can be used for real-time quantification of MMP enzymatic activity. Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 is an elongated peptide of MMP substrate (FS-1) and is active against collagenases (MMP-1, MMP-8, MMP-13 ) and MT1-MMP with higher specificity constants than FS-1 [1]. (Ex/Em=325 nm/400 nm)
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-105285
CAS. Nr.: 946846-83-9
Reinheit:  99.54%
Synonyms: Neu-P11
Piromelatine (Neu-P11) is a melatonin MT1/MT2 receptor agonist, serotonin 5-HT1A/5-HT1D agonist, and serotonin 5-HT2B antagonist. Piromelatine (Neu-P11) possesses sleep promoting, analgesic, anti-neurodegenerative, anxiolytic and antidepressant potentials. Piromelatine (Neu-P11) also possesses pain-related P2X3, TRPV1, and Nav1.7 channel-inhibition capacities [1] .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-14803
CAS. Nr.: 609799-22-6
Reinheit:  99.68%
Synonyms: BMS-214778; VEC-162
Target:  

Melatonin Receptor

Forschungsgebiete:  

Neurological Disease Endocrinology

Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24) [1] .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-101358
CAS. Nr.: 134865-70-6
Reinheit:  99.54%
Synonyms: AH-002
Target:  

Melatonin Receptor

Forschungsgebiete:  

Neurological Disease

8-M-PDOT (AH-002) is a selective melatonin MT2 receptor agonist. 8-M-PDOT is 5.2-fold selective for MT2 over MT1 receptors. 8-M-PDOT binds human recombinant MT2 and MT2 receptors with pKi values of 8.23 and 8.95 respectively. 8-M-PDOT has anxiolytic-like activity [1] .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-133113
CAS. Nr.: 152302-45-9
Reinheit:  99.89%
Target:  

5-HT Receptor

Forschungsgebiete:  

Neurological Disease

7-Desmethyl-agomelatine is a metabolite of Agomelatine. Agomelatineis a potent agonist at melatonin receptors (MT1 and MT2), and also is an antagonist of 5-HT2C [1] .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-114962
CAS. Nr.: 180304-07-8
Reinheit:  99.88%
Target:  

Melatonin Receptor

Forschungsgebiete:  

Neurological Disease

S-22153 is a potent melatonin receptor antagonist with EC50 values of 19 nM, 4.6 nM for hMT1 and hMT2 melatonin receptor, respectively. S-22153 has Ki values of 8.6 nM (CHO cells) and 16.3 nM (HEK cells) for hMT1, and 6.0 nM (CHO cells) and 8.2 nM (HEK cells) for hMT2. S-22153 is a specific ligand of MT1 and MT2 melatonin receptors subtypes [1] .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P81119
Synonyms: mtR1A_HUMAN; Melatonin receptor type 1A; Melatonin Receptor 1A; Mel-1A-R; Mel1a receptor; mt1; mt 1; Mel 1A R;

Host:  

Rabbit

Application:  

WB, ELISA, IHC-P, IHC-F, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Art. -Nr.: HY-111976
CAS. Nr.: 2060573-82-0
Reinheit:  99.78%
Forschungsgebiete:  

Cancer

MT1 is a bivalent chemical probe of BET bromodomains, with an IC50 of 0.789 nM for BRD4(1) [1].
loading...
    loading...
Art. -Nr.: HY-103005S
CAS. Nr.: 1246812-22-5
Reinheit:  ≥99.0%
Ramelteon metabolite M-II-d3 is the deuterium labeled Ramelteon metabolite M-II. Ramelteon metabolite M-II is the major metabolite of Ramelteon, with IC50s of 208 pM, 1470 pM for human melatonin receptors (MT1 or MT2). Ramelteon is a selective melatonin agonist [1] .
loading...
    loading...
Art. -Nr.: HY-103005
CAS. Nr.: 896736-21-3
Reinheit:  98.24%
Ramelteon metabolite M-II is the major metabolite of Ramelteon, with IC50s of 208 pM, 1470 pM for human melatonin receptors (MT1 or MT2). Ramelteon is a selective melatonin agonist.
loading...
    loading...
Art. -Nr.: HY-A0014S1
CAS. Nr.: 1432057-38-9
Synonyms: TAK-375-d3
Ramelteon-d3 (TAK-375-d3) is a deuterium-labelled Ramelteon (HY-A0014). Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation.
loading...
    loading...
Art. -Nr.: HY-P4123
CAS. Nr.: 1231898-26-2
Target:  

MMP

TAT (47-57) GGG-Cys (Npys) is a cell-penetrating peptide and delivery carrier derived from TAT. TAT (47-57) GGG-Cys (Npys) facilitates the translocation of conjugated drug molecules across cell membranes. TAT (47-57) GGG-Cys (Npys) acts as a delivery carrier for MT1-MMP inhibitors. TAT (47-57) GGG-Cys (Npys) is applicable to research on diseases associated with MT1-MMP activity, such as cancer, arthritis, heart disease, and vascular disorders [1].
loading...
    loading...